Delete search term

Header

Main navigation

Local brain retention for better brain cancer drugs

Description

Glioblastoma is one of the most common primary brain neoplasms with very limited options for treatments and a low survival rate. For the last 40 years, no significant progress has been made for the therapy of this malignancy. The project aims at the further establishment of a technology and the development of drug candidates for the treatment of patients diagnosed with glioblastoma. 

Key Data

Deputy Projectlead

Project team

Dominique Greuter, Jon Grolimund

Project partners

InCephalo AG; Universität Basel; Universität Zürich

Project status

ongoing, started 03/2024

Funding partner

Innosuisse - Innovationsprojekt